13.00
price down icon2.78%   -0.3499
 
loading

Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten

pulisher
Mar 12, 2026

Discipline and Rules-Based Execution in WVE Response - Stock Traders Daily

Mar 12, 2026
pulisher
Mar 11, 2026

Dynamic SXSW panel reshapes obesity treatment narrative, WAVE Life Sciences asserts - Traders Union

Mar 11, 2026
pulisher
Mar 10, 2026

Canaccord Genuity Boosts Price Target for WAVE Life Sciences (WV - GuruFocus

Mar 10, 2026
pulisher
Mar 10, 2026

WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) - Benzinga

Mar 10, 2026
pulisher
Mar 10, 2026

WAVE Life Sciences (NASDAQ:WVE) Given New $52.00 Price Target at Canaccord Genuity Group - MarketBeat

Mar 10, 2026
pulisher
Mar 09, 2026

Wave Life Sciences to present WVE-006 trial data at ATS - Investing.com Nigeria

Mar 09, 2026
pulisher
Mar 08, 2026

Wave Life Sciences (WVE) Is Down 5.8% After Wider Losses And WVE-006 Accelerated Approval PushWhat's Changed - simplywall.st

Mar 08, 2026
pulisher
Mar 07, 2026

Wave Life Sciences Hits Day Low of $13.59 Amid Price Pressure - Markets Mojo

Mar 07, 2026
pulisher
Mar 07, 2026

Wave Life Sciences Bets on Data Over Near-Term Revenue - TipRanks

Mar 07, 2026
pulisher
Mar 06, 2026

WVE: Wedbush Raises Price Target for WAVE Life Sciences, Reaffir - GuruFocus

Mar 06, 2026
pulisher
Mar 06, 2026

Wave Life Sciences (WVE) Valuation Check After New RNA Editing And Obesity Trial Updates - simplywall.st

Mar 06, 2026
pulisher
Mar 06, 2026

Wedbush Forecasts Strong Price Appreciation for WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Wave Life Sciences (WVE) Anticipates Positive Developments with WVE-007 Data - GuruFocus

Mar 06, 2026
pulisher
Mar 06, 2026

Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference - Sahm

Mar 06, 2026
pulisher
Mar 06, 2026

Wave Life Sciences to present WVE-006 trial data at ATS By Investing.com - Investing.com Canada

Mar 06, 2026
pulisher
Mar 05, 2026

Wave Life Sciences announces acceptance of late-breaking oral presentation on Wve-006 for alpha-1 antitrypsin deficiency at the American Thoracic Society international conference - marketscreener.com

Mar 05, 2026
pulisher
Mar 05, 2026

Q1 EPS Forecast for WAVE Life Sciences Raised by Analyst - MarketBeat

Mar 05, 2026
pulisher
Mar 04, 2026

FY2029 Earnings Forecast for WVE Issued By HC Wainwright - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

Wave Life Sciences Obesity Proof Of Concept Sparks Focus On Pipeline Upside - simplywall.st

Mar 03, 2026
pulisher
Mar 03, 2026

WVE SEC FilingsWave Life Scienc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with 140% Upside Potential - DirectorsTalk Interviews

Mar 03, 2026
pulisher
Mar 03, 2026

How Strong Q4 Revenue Amid Deeper Losses At Wave Life Sciences (WVE) Has Changed Its Investment Story - Yahoo Finance

Mar 03, 2026
pulisher
Mar 02, 2026

Wave Life Sciences (WVE) Earnings Call Transcript - AOL.com

Mar 02, 2026
pulisher
Mar 02, 2026

Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 02, 2026
pulisher
Mar 02, 2026

HC Wainwright Reiterates "Buy" Rating for WAVE Life Sciences (NASDAQ:WVE) - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near - Yahoo Finance

Mar 02, 2026
pulisher
Mar 01, 2026

Artisan Partners Limited Partnership Trims Stake in WAVE Life Sciences Ltd. $WVE - MarketBeat

Mar 01, 2026
pulisher
Feb 28, 2026

How Mixed Q4 Results, Obesity Data and Cash Runway News At Wave Life Sciences (WVE) Has Changed Its Investment Story - simplywall.st

Feb 28, 2026
pulisher
Feb 28, 2026

Wave Life Sciences Ltd. (WVE): A Bull Case Theory - Finviz

Feb 28, 2026
pulisher
Feb 28, 2026

Primecap Management Co. CA Has $13.90 Million Position in WAVE Life Sciences Ltd. $WVE - MarketBeat

Feb 28, 2026
pulisher
Feb 28, 2026

Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings - Yahoo Finance

Feb 28, 2026
pulisher
Feb 27, 2026

Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Insider Sells 33,194 Shares of Stock - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Wave Life Sciences (WVE) officer nets 33,194-share sale after option exercises - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

WAVE Life Sciences (NASDAQ:WVE) Shares Down 10.6%What's Next? - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

WAVE Life Sciences Q4 Earnings Call Highlights - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Wave Life Sciences (WVE) Quarterly Loss Deepens Bear Narratives On Profitability And Cash Burn - simplywall.st

Feb 27, 2026
pulisher
Feb 27, 2026

Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight - GuruFocus

Feb 27, 2026
pulisher
Feb 26, 2026

Wave Life Sciences: Q4 Earnings Snapshot - theheraldreview.com

Feb 26, 2026
pulisher
Feb 26, 2026

WAVE Life Sciences Ltd (WVE) Q4 2025 Earnings Call Highlights: N - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences at Oppenheimer Conference: Strategic Insights on RNA Medicines - Investing.com Australia

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences (WVE) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences Posts Wider FY25 Loss, Highlights Progress Across RNA Pipeline - Nasdaq

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings call transcript: Wave Life Sciences Q4 2025 sees revenue drop - Investing.com

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences (WVE) Reports Strong Q4 Revenue and Advances in Obesity Treatment - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Investing News Network

Feb 26, 2026
pulisher
Feb 26, 2026

WAVE Life Sciences Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences: Fourth Quarter Financial Overview - Bitget

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences Swings to Q4 Net Loss, Revenue Falls - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings Flash (WVE) Wave Life Sciences Posts Q4 Loss $0.30 a Share, vs. FactSet Est of $0.26 Loss - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings Flash (WVE) Wave Life Sciences Ltd. Reports Q4 Revenue $17.2M, vs. FactSet Est of $16.1M - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

WAVE LIFE SCIENCES ($WVE) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences Ltd earnings missed by $0.03, revenue topped estimates By Investing.com - Investing.com India

Feb 26, 2026
pulisher
Feb 26, 2026

Wave Life Sciences Highlights 2025 Results and Obesity Progress - TipRanks

Feb 26, 2026
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):